The 17th edition of CPHI & PMEC India, organised by Informa Markets in India which ran for three days to 27 November 2024 at the India Expo Centre, Greater Noida, Delhi-NCR, showcased the robust potential of India’s pharmaceutical industry, which is projected to grow to $130bn by 2030.
Over 2,000 exhibitors and 50,000 visitors attended from more than 150 countries. The shows showcased over 10,000 products spanning pharma machinery, packaging, analytical instruments, laboratory technologies, ingredients, and beyond,
The expo garnered strong support from prominent industry associations, including CIPI, FOPE (Federation of Pharma Entrepreneurs), IPEC India, and Pharmexcil.
Mr Namit Joshi, vice-chairman, Pharmexil, said: "The Indian pharmaceutical industry has solidified its global position as the 'Pharmacy of the World' and earned recognition as the 'Healers of the World' through its exceptional contribution to Covid-19 vaccine distribution. With exports nearing $27.84bn and innovative advancements like nanoparticles and improved drug delivery systems, India continues to lead. Integrating IT with pharmaceuticals will further strengthen its role, paving the way for dominance in biologics and biosimilars. CPHI & PMEC India is instrumental in showcasing this progress and reinforcing India's potential to serve global healthcare needs.”
Mr Yogesh Mudras, managing director, Informa Markets in India, said the Indian pharmaceutical industry had evolved into a vibrant sector, and now ranks third globally in pharmaceutical production by volume and 14th by value, contributing approximately 1.72% to the nation’s GDP.
Factors that contribute to the industry’s success, according to Mudras, are low manufacturing cost, which is 30%-35% lower than in the US and Europe, cost-efficient R&D at 87% less than developed markets, and an abundant pool of skilled labour.
The CPHI & PMEC India expo this year included a Start Up Pavilion showcasing emerging pharma disruptors.
Day 1 of the event also showcased the Pharma Connect Congress, which addressed pivotal themes shaping the pharmaceutical landscape, and a Pharma Leaders Roundtable, a closed-door session for senior leaders to explore transformative trends and challenges.
Originating from CPhI Worldwide – CPhI India has become South Asia’s leading Pharma meeting place covering every step of the supply chain from drug discovery to finished dosage.
